INTERCURE LTD (INCR)

IL0011063760 - Common Stock

1.65  +0.02 (+1.23%)

INTERCURE LTD

NASDAQ:INCR (1/14/2025, 10:58:17 AM)

1.65

+0.02 (+1.23%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-821.9%
Sales Q2Q%236.68%
CRS62.19
6 Month-29.13%
Overview
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)N/A N/A
Ins Owners39.6%
Inst Owners12.95%
Market Cap75.52M
Shares45.77M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
Short Float %0.17%
Short Ratio0.99
IPO07-26 2007-07-26
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

INCR Daily chart

Company Profile

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Company Info

INTERCURE LTD

Medinat HaYehudim 85

Herzliya 27604

P: 972774605012

CEO: Alistair Macdonald

Employees: 270

Website: https://www.intercure.co/

INCR News

News Image25 days ago - Intercure Ltd.InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

The funding may increase to NIS 107M to support the expansion of the facility in collaboration with the "Tkumah" administration, post-war. The funding includes...

News Image5 months ago - InterCure Ltd.InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both...

News Image5 months ago - InterCureInterCure Announces Expansion of its Strategic partnership with Cookies to Germany
News Image8 months ago - InterCure Ltd.InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
News Image9 months ago - InterCure Ltd.InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
News Image10 months ago - InterCure Ltd.InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

INCR Twits

Here you can normally see the latest stock twits on INCR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example